These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 14566479)

  • 1. Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
    Röttinger EM; Bartkowiak D; Bunjes D; Wennauer R; Dohr D
    Strahlenther Onkol; 2003 Oct; 179(10):702-7. PubMed ID: 14566479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
    Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
    Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation. No increase of proinflammatory cytokine levels of TNF-alpha].
    Mutschler J; Steinbach G; Bunjes D; Reske SN; Buchmann I
    Nuklearmedizin; 2009; 48(1):30-6. PubMed ID: 19212609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation.
    Döbert N; Martin H; Kranert WT; Menzel C; Klein SA; Mose S; Grünwald F
    Clin Nucl Med; 2003 Sep; 28(9):738-42. PubMed ID: 12972995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
    Ringhoffer M; Blumstein N; Neumaier B; Glatting G; von Harsdorf S; Buchmann I; Wiesneth M; Kotzerke J; Zenz T; Buck AK; Schauwecker P; Stilgenbauer S; Döhner H; Reske SN; Bunjes D
    Br J Haematol; 2005 Aug; 130(4):604-13. PubMed ID: 16098076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
    Labar B; Bogdanić V; Nemet D; Mrsić M; Vrtar M; Grgić-Markulin L; Kalenić S; Vujasinović S; Presecki V; Jakić-Razumović J
    Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
    Buchmann I; Bunjes D; Kotzerke J; Martin H; Glatting G; Seitz U; Rattat D; Buck A; Döhner H; Reske SN
    Cancer Biother Radiopharm; 2002 Apr; 17(2):151-63. PubMed ID: 12030109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST).
    Heinzelmann F; Ottinger H; Müller CH; Allgaier S; Faul C; Bamberg M; Belka C
    Strahlenther Onkol; 2006 Apr; 182(4):222-30. PubMed ID: 16622624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
    Zenz T; Schlenk RF; Glatting G; Neumaier B; Blumstein N; Buchmann I; von Harsdorf S; Ringhoffer M; Wiesneth M; Keller F; Kotzerke J; Röttinger E; Stilgenbauer S; Döhner H; Reske SN; Bunjes D
    J Nucl Med; 2006 Feb; 47(2):278-86. PubMed ID: 16455634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
    Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20 years of experience in static intensity-modulated total-body irradiation and lung toxicity. Results in 257 consecutive patients.
    Schneider RA; Schultze J; Jensen JM; Hebbinghaus D; Galalae R; Kimmig BN
    Strahlenther Onkol; 2007 Oct; 183(10):545-51. PubMed ID: 17896085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation.
    Lawton CA; Cohen EP; Murray KJ; Derus SW; Casper JT; Drobyski WR; Horowitz MM; Moulder JE
    Bone Marrow Transplant; 1997 Dec; 20(12):1069-74. PubMed ID: 9466280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
    Miralbell R; Sancho G; Bieri S; Carrió I; Helg C; Brunet S; Martin PY; Sureda A; Gomez De Segura G; Chapuis B; Estorch M; Ozsahin M; Keller A
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):809-16. PubMed ID: 14967438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radiation dose on the development of mixed haemopoietic chimerism following T cell-depleted allogeneic bone marrow transplantation.
    Chalmers EA; Sproul AM; Mills KI; Stewart J; McNee S; Jones R; Barrett A; Simpson E; Gibson BE; Robertson AG
    Bone Marrow Transplant; 1992 Nov; 10(5):425-30. PubMed ID: 1464004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation.
    Quaranta BP; Halperin EC; Kurtzberg J; Clough R; Martin PL
    Cancer; 2004 Aug; 101(4):845-50. PubMed ID: 15305418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal toxicity in children undergoing total body irradiation for bone marrow transplant.
    Esiashvili N; Chiang KY; Hasselle MD; Bryant C; Riffenburgh RH; Paulino AC
    Radiother Oncol; 2009 Feb; 90(2):242-6. PubMed ID: 18973960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
    Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
    Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
    Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR
    Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
    Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
    J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.